Atai Life Sciences (ATAI) Revenue & Revenue Breakdown
Atai Life Sciences Revenue Highlights
Main Segment (Y)
Research And Development Services
Atai Life Sciences Revenue by Period
Atai Life Sciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -100.00% |
2022-12-31 | $233.00K | -98.86% |
2021-12-31 | $20.38M | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Atai Life Sciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $18.00K | -79.31% |
2023-09-30 | $87.00K | -49.42% |
2023-06-30 | $172.00K | 364.86% |
2023-03-31 | $37.00K | -2.63% |
2022-12-31 | $38.00K | 58.33% |
2022-09-30 | $24.00K | -85.88% |
2022-06-30 | $170.00K | 100.00% |
2022-03-31 | - | -100.00% |
2021-12-31 | $230.00K | -13.53% |
2021-09-30 | $266.00K | 100.00% |
2021-06-30 | - | -100.00% |
2021-03-31 | $19.88M | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Atai Life Sciences Revenue Breakdown
Atai Life Sciences Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 |
---|---|---|---|
Research And Development Services | $300.00K | $200.00K | $600.00K |
Quarterly Revenue by Product
Product/Service | Sep 22 | Jun 22 | Dec 21 | Sep 21 |
---|---|---|---|---|
Research And Development Services | $200.00K | $200.00K | $200.00K | $400.00K |
Atai Life Sciences Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Jun 22 | Dec 21 | Sep 21 |
---|---|---|---|
Research And Development Services | $200.00K | $200.00K | $400.00K |
Atai Life Sciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
FBIO | Fortress Biotech | $59.66M | $13.03M |
ITOS | iTeos Therapeutics | $12.60M | - |
MOLN | Molecular Partners | $7.04M | $2.74M |
SEEL | Seelos Therapeutics | $2.20M | $579.00K |
VCNX | Vaccinex | $570.00K | $232.00K |
OPT | Opthea | $108.41K | $61.27K |
BPTH | Bio-Path | - | - |
GHRS | GH Research | - | $80.00K |
ATAI | Atai Life Sciences | - | - |
ELYM | Eliem Therapeutics | - | - |
EWTX | Edgewise Therapeutics | - | - |
MNMD | Mind Medicine (MindMed) | - | - |
ATAI Revenue FAQ
What is Atai Life Sciences’s yearly revenue?
Atai Life Sciences's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $233K, representing a decrease of -98.86% compared to 2021. ATAI's yearly revenue for 2021 was $20.38M, representing an increase of 100.00% compared to 2020.
What is Atai Life Sciences’s quarterly revenue?
Atai Life Sciences's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023). ATAI's quarterly revenue for Q4 2023 was $18K, a -79.31% decrease from the previous quarter (Q3 2023), and a -52.63% decrease year-over-year (Q4 2022).
What is Atai Life Sciences’s revenue growth rate?
Atai Life Sciences's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.
What are Atai Life Sciences’s revenue streams?
Atai Life Sciences's revenue streams in c 23 are Research And Development Services
What is Atai Life Sciences’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Atai Life Sciences was Research And Development Services. This segment made a revenue of $300K, representing 100.00% of the company's total revenue.